Dear Reprocessing News Readers, 

I hope this letter finds you, your families and colleagues safe and well. These are trying times. I’m proud of how the single use device reprocessing industry has continued to work with our hospital partners during the COVID-19 pandemic.  Our members have played an essential role in providing hospitals with FDA-regulated or CE marked, clean, disinfected and sterile medical devices.  Some commonly reprocessed items, such as pulse oximeters, are playing a major role in helping to detect COVID-related silent hypoxia. 

As the world wrestles to address COVID-19, we are receiving an unprecedented volume of inquiries from healthcare systems, Ministries of Health, regulatory agencies, and other device manufacturers regarding our members’ reprocessing capabilities for medical products in urgent demand.  AMDR Statement On COVID-19 Response clarifies our members’ commitment during this difficult time.

Reprocessing strengthens hospitals by reducing costs, increasing supply chain resilience, and eliminating waste. Hospitals that expand professional reprocessing programs can address the cost burden association with COVID-19, better control their supply chain and invest savings to prepare for future threats, among other areas.

Please visit the COVID-19 page on our website for great articles and more on the current pandemic.  Follow us on twitter and LinkedIn for breaking news and updates from our members and friends. 

Dan Vukelich, Esq., CAE
President & CEO
Association of Medical Device Reprocessors
www.amdr.org